CancerIQ: Funding, Investors & Team (Sep 2026)
CancerIQ’s technology enables hospitals to identify, evaluate and manage entire patient populations based on individual genetic risk factors. By analyzing family history, running predictive risk models and automating NCCN guidelines, CancerIQ empowers community-based providers with the genetic expertise to prevent cancer or catch it early. The platform has been rapidly adopted by some of the top health systems in the country and fully integrates with genetics laboratories, EHRs, and specialty software vendors to streamline workflow, guide clinician decision making, achieve cost savings, and – most importantly – improve patient outcomes. Learn more about how CancerIQ is scaling the use of genetic testing to predict, preempt and prevent disease at canceriq.com.
CancerIQ has raised $14.0M across 2 funding rounds on record, the most recent an undisclosed round announced in Aug 2024.
CancerIQ Company Profile and Key Stats
Latest funding round on record: Aug 2024.
CancerIQ Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
CancerIQ raised $14.0M in a Series B announced in Mar 2022.
2.4 years later, an undisclosed round was announced in Aug 2024 with no disclosed amount.
CancerIQ Founders and Leadership Team
Contact details for the CancerIQ team: 1 of 2 have an email address on file.
Start 14-day free trial →CancerIQ Funding Compared to Other Biotechnology Startups
Funded Startups Like CancerIQ in Biotechnology and Chicago
Companies Similar to CancerIQ
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
CancerIQ Funding FAQs
What does CancerIQ do?
CancerIQ’s technology enables hospitals to identify, evaluate and manage entire patient populations based on individual genetic risk factors. By analyzing family history, running predictive risk models and automating NCCN guidelines, CancerIQ empowers community-based providers with the genetic expertise to prevent cancer or catch it early. The platform has been rapidly adopted by some of the top health systems in the country and fully integrates with genetics laboratories, EHRs, and specialty software vendors to streamline workflow, guide clinician decision making, achieve cost savings, and – most importantly – improve patient outcomes. Learn more about how CancerIQ is scaling the use of genetic testing to predict, preempt and prevent disease at canceriq.com.
How much funding has CancerIQ raised?
CancerIQ has raised $14.0M across 2 rounds on record.
When did CancerIQ last raise funding?
CancerIQ's most recent funding round on record was announced in Aug 2024. The amount was not disclosed.
Who founded CancerIQ?
FundedIQ lists Olufunmilayo Olopade (Founder) at CancerIQ.
Who is the CEO of CancerIQ?
Feyi Olopade is listed as CEO at CancerIQ.
Where is CancerIQ headquartered?
CancerIQ is based in Chicago, Illinois, United States.
How many employees does CancerIQ have?
CancerIQ is in the 11-50 employee band.
About FundedIQ's CancerIQ Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CancerIQ is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.